VIB Center for Medical Biotechnology, VIB, Zwijnaarde, Technologiepark 71, 9052 Ghent (Zwijnaarde), Belgium.
Department of Biochemistry and Microbiology, Ghent University, Technologiepark 71, 9052 Ghent (Zwijnaarde), Belgium.
Glycobiology. 2020 Aug 20;30(9):735-745. doi: 10.1093/glycob/cwaa023.
The deoxy sugar l-fucose is frequently found as a glycan constituent on and outside living cells, and in mammals it is involved in a wide range of biological processes including leukocyte trafficking, histo-blood group antigenicity and antibody effector functions. The manipulation of fucose levels in those biomedically important systems may provide novel insights and therapeutic leads. However, despite the large established sequence diversity of natural fucosidases, so far, very few enzymes have been characterized. We explored the diversity of the α-l-fucosidase-containing CAZY family GH29 by bio-informatic analysis, and by the recombinant production and exploration for fucosidase activity of a subset of 82 protein sequences that represent the family's large sequence diversity. After establishing that most of the corresponding proteins can be readily expressed in E. coli, more than half of the obtained recombinant proteins (57% of the entire subset) showed activity towards the simple chromogenic fucosylated substrate 4-nitrophenyl α-l-fucopyranoside. Thirty-seven of these active GH29 enzymes (and the GH29 subtaxa that they represent) had not been characterized before. With such a sequence diversity-based collection available, it can easily be used to screen for fucosidase activity towards biomedically relevant fucosylated glycoproteins. As an example, the subset was used to screen GH29 members for activity towards the naturally occurring sialyl-Lewis x-type epitope on glycoproteins, and several such enzymes were identified. Together, the results provide a significant increase in the diversity of characterized GH29 enzymes, and the recombinant enzymes constitute a resource for the further functional exploration of this enzyme family.
岩藻糖是一种常见的脱氧糖,存在于活细胞内外的聚糖成分中,在哺乳动物中,它参与了广泛的生物学过程,包括白细胞迁移、组织血型抗原性和抗体效应功能。在这些具有重要生物医学意义的系统中操纵岩藻糖水平可能提供新的见解和治疗线索。然而,尽管天然岩藻糖苷酶具有很大的序列多样性,但迄今为止,只有很少的酶被表征。我们通过生物信息学分析和对代表该家族大序列多样性的 82 个蛋白质序列的亚组的重组生产和岩藻糖苷酶活性的探索,研究了含有α-L-岩藻糖苷酶的 CAZY 家族 GH29 的多样性。在确定大多数相应的蛋白质可以在大肠杆菌中容易表达之后,获得的重组蛋白中有一半以上(整个亚组的 57%)对简单的显色岩藻糖基化底物 4-硝基苯基α-L-岩藻吡喃糖苷表现出活性。其中 37 种具有活性的 GH29 酶(及其代表的 GH29 亚类)以前没有被表征过。有了这样一个基于序列多样性的集合,它可以很容易地用于筛选对生物医学相关岩藻糖基化糖蛋白具有活性的岩藻糖苷酶。例如,该亚组用于筛选 GH29 成员对糖蛋白上天然存在的唾液酸-Lewis x 型表位的活性,鉴定出了几种这样的酶。总之,这些结果大大增加了已鉴定的 GH29 酶的多样性,重组酶构成了进一步探索该酶家族功能的资源。